Description: | Methyl 4-[(3-chloro-2-fluorophenyl)methyl]-1-piperazinecarboxylate is an intermediate in the synthesis of CK 1827452 (C544000), a promising new drug in systolic heart failure. It accelerates the transition of myosin into the force-generating state without affecting cardiac myocyte calcium homeostasis. CK 1827452 increases cardiac function by increasing the duration of ejection without changing the rates of contraction. |
Molecular Weight: | 286.73 |
Molecular Formula: | C13H16ClFN2O2 |
References: | Meijs, M. et al. Eur. J. Heart. Fail., 14, 232 (2012); Malik, F. et al. J. Mol. Cell. Card., 51, 454 (2011). |
Customer Support
If the product you need is not in our catalog, please contact us in time to submit your needs. You can help our website get better and better. Why not submit the request today?
Customer Centered
Related Functional Groups
Other Building Blocks
N-((4-Oxo-1-phenyl-4,7-dihydro-1H-pyrazolo[3,4-d]pyrimidin-6-yl)methyl)acetamide
Customers Also Viewed
Copyright © 2024 BOC Sciences. All rights reserved.
Our Products